Tadahiko Kohno

Immunology and Microbiology · Life Sciences

30h-index5.0kcitations55works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Response and Inflammation(16), Monoclonal and Polyclonal Antibodies Research(8), Immunotherapy and Immune Responses(7), Enzyme Structure and Function(7), RNA Interference and Gene Delivery(5)

Publications55 total

baboon the human TNF receptor type I (sTNFR-I) construct in Development of a novel, nonimmunogenic, soluble
2015
Evaluation of DNA Damage Response After Carbon-Ion Beam Irradiation in p53-Mutant Cancer Cells
International Journal of Radiation Oncology*Biology*Physics·2014
Characterization of <sup>64</sup>Cu-DOTA-Conatumumab: A PET Tracer for In Vivo Imaging of Death Receptor 5
Journal of Nuclear Medicine·2011· 13 citedOpen Access
Differences in binding and effector functions between classes of TNF antagonists
Cytokine·2009· 128 cited
Structure of the K349P mutant of Gi alpha 1 subunit bound to GDP
2008
Neutralization of Tumor Necrosis Factor (TNF) by Antibody but not TNF Receptor Fusion Molecule Exacerbates Chronic Murine Tuberculosis
The Journal of Infectious Diseases·2007· 127 citedOpen Access
Binding Characteristics of Tumor Necrosis Factor Receptor-Fc Fusion Proteins vs Anti-Tumor Necrosis Factor mAbs
Journal of Investigative Dermatology Symposium Proceedings·2007· 89 citedOpen Access
Construction and Purification of the Murine p75-murine IgG1 Fusion Protein
Journal of Investigative Dermatology Symposium Proceedings·2007· 11 citedOpen Access
Pharmacodynamic Effects of the Murine p75-Fc Fusion Protein in Mice
Journal of Investigative Dermatology Symposium Proceedings·2007· 12 citedOpen Access
Biophysical Characterization of Structural Properties and Folding of Interleukin-1 Receptor Antagonist
Journal of Molecular Biology·2007· 17 cited
Pentaketide chromone synthase (M207G mutant)
2005
Pentaketide chromone synthase complexed with coenzyme A
2005
Anion Binding and Controlled Aggregation of Human Interleukin-1 Receptor Antagonist
Biochemistry·2005· 44 cited
Potent activity of soluble B7RP‐1‐Fc in therapy of murine tumors in syngeneic hosts
International Journal of Cancer·2002· 33 citedOpen Access
Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon
Journal of Applied Physiology·2001· 14 cited
Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes
Blood·2001· 385 citedOpen Access
Tumor Necrosis Factor (TNF)–α–Induced Interleukin‐8 in Human Blood Cultures Discriminates Neutralization by the p55 and p75 TNF Soluble Receptors
The Journal of Infectious Diseases·2000· 36 citedOpen Access
Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS
International Immunology·2000· 134 citedOpen Access
Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.
PubMed·2000· 44 cited
T-cell co-stimulation through B7RP-1 and ICOS
Nature·1999· 760 cited
page 1 of 3Next →

Frequent Co-authors

John R. Roth(6), Joseph Yourno(5), Lyle L. Moldawer(3), Steven K. Yoshinaga(3), John Whoriskey(3), Sanjay D. Khare(3), Tom Horan(3), Carl K. Edwards(3), Krzysztof Selmaj(3), James S. Louie(3), James E. Seely(3), Steven W. Martin(3), Marco Coccia(2), David Brankow(2), Tianang Dai(2), Ariela Hui(2), Gwyneth Van(2), Michael Brewer(2), Charles H. Squires(2), Richard Thompson(2)